Email bulletin archive Archive December 2021 EASL-Lancet Liver Commission calls for a paradigm shift in European responses to liver disease Advanced fibrosis in people with NAFLD increases the risk of liver complications Three-drug regimen plus ribavirin cures the hardest-to-treat hepatitis C patients Australia on track to eliminate hepatitis C among gay and bisexual men before 2030 Hepatitis B treatment for all who need it an "achievable public health goal" for Malawi Is this your copy of the infohep news bulletin? November 2021 News from The Liver Meeting People with liver cirrhosis have weaker responses to the Pfizer and Moderna SARS-CoV-2 vaccines COVID-19 vaccine protection is ‘lower and slower’ in people with cirrhosis Treatment for hepatitis B and C fell in 2020 due to COVID-19, global survey finds Hepatitis C elimination: less than 25% of people with hepatitis C diagnosed globally Hepatitis C treatment in US declined from 2015 to 2020 Is this your copy of the infohep news bulletin? October 2021 Cognitive function improves after hepatitis C cure New cases of hepatitis C have fallen among gay and bisexual men with HIV in France Rapid hepatitis C treatment improves cure rate in young people who inject drugs People with HIV taking newer antiretrovirals at higher risk of fatty liver disease Is this your copy of the infohep news bulletin? September 2021 Testing COVID-19 patients for viral hepatitis does not detect numerous undiagnosed cases People with diabetes or high alcohol consumption at higher risk of late hepatitis C diagnosis Short stay in prison increases the risk of hepatitis for people who use drugs Ultra-short course treatment for hepatitis C: high failure rate but does not compromise second-line treatment Rapid HCV testing in Australia Low sign up by community pharmacies in England to offer hepatitis C antibody testing Is this your copy of the infohep news bulletin? August 2021 Recommendations and guidance on hepatitis C virus self-testing US CDC recommends third dose of Moderna or Pfizer COVID-19 vaccines for organ transplant recipients Hepatitis C virtually eliminated in people with HIV in the Netherlands High hepatitis C cure rate in Thai study of community-based treatment Japanese study shows benefits of treating hepatitis C early Food insecurity raises the risk of death in people with fatty liver disease Is this your copy of the infohep news bulletin? July 2021 News from the 2021 International Liver Congress Weaker COVID-19 vaccine responses seen in people with advanced liver fibrosis COVID-19 vaccine responses are weaker in liver transplant patients Advanced cirrhosis or alcohol use disorder raised the risk of COVID-19 death in France Antiviral treatments for hepatitis B may reduce severity of COVID-19 or risk of infection Bulevirtide appears safe and effective for hepatitis D Peer support improved hepatitis C treatment uptake and completion in England Reflex testing successfully uncovers hidden hepatitis C cases in Scotland Immunotherapy plus arterial infusion chemotherapy shows promise for advanced liver cancer World Hepatitis Day 2021: Hepatitis can't wait Is this your copy of the infohep news bulletin? June 2021 Liver transplant outcomes improve in people with HIV and hepatitis C What happens after curing hepatitis C? Avoiding, minimising or accepting the risks of re-infection HIV treatment choice affects improvement in liver after hepatitis C cure High prevalence of viral hepatitis among healthcare workers in Africa Malaysia registers first hepatitis C treatment developed through South-South co-operation FDA approves oral pellet version of Gilead's Epclusa for use in young people with hepatitis C News from The International Liver Congress Is this your copy of the infohep news bulletin? May 2021 WHO says 2030 hepatitis elimination targets will not be met without massive scale-up of testing and treatment Developing global health sector strategies on HIV, viral hepatitis and sexually transmitted infections for 2022-2030 COVID-19 reduced US hepatitis C testing, diagnosis and treatment Liver function improves in most people with cirrhosis after hepatitis C cure Australia: recent drug users more likely to start hepatitis C treatment New report shows discriminatory sobriety restrictions undermine public health efforts to eliminate hepatitis C Is this your copy of the infohep news bulletin? April 2021 Screen for hepatitis C while vaccinating for COVID-19, say Spanish experts Hepatitis C testing in gay and bisexual men with HIV below target, US study finds Swiss opioid substitution therapy programme reports strong progress towards hepatitis C elimination Community-wide hepatitis C elimination campaign in Seattle increases number treated tenfold Reinfection after hepatitis C cure predicted by sexually transmitted infections HepB Global Community: a global online forum supporting people affected by hepatitis B Is this your copy of the infohep news bulletin? March 2021 12 good practices that should be part of the hepatitis C standard of care People with HIV and hepatitis B should have ongoing monitoring for liver cancer Pancreatic and colorectal cancer risk raised in people with hepatitis C Outreach to homeless in England achieved large-scale testing for hepatitis C during the COVID-19 lockdown Catch up on the EASL Digital Liver Cancer Summit Is this your copy of the infohep news bulletin? February 2021 Hepatitis C does not raise the risk of death from COVID-19 COVID-19 slows viral hepatitis elimination, global survey finds COVID-19 hits viral hepatitis care for vulnerable populations Hepatitis C treatment reduces stroke and heart attack risk Hepatitis C declining among drug users in UK High adherence and hepatitis C cure rates in active drug and alcohol users WHA releases new messaging guide for global fund advocates Is this your copy of the infohep news bulletin? January 2021 Will people with liver disease be prioritised for COVID-19 vaccination? Questions about COVID-19 vaccination for people with liver disease: guidance from patient associations and health bodies Public-sector hepatitis C treatment programmes expanding in lower- and middle-income countries What's needed to eliminate hepatitis C in people with HIV in Scotland? Hepatitis C elimination in France feasible if new infections in gay and bisexual men decline HIV doubles the risk of liver fibrosis by middle age, without viral hepatitis Launch of new international liver patients’ organisation: Liver Patients International Catch up on the World Hepatitis Alliance webinar on hepatitis B diagnostics Is this your copy of the infohep news bulletin? 2022202120202019201820172016201520142013 Other pages in this section Latest news All the news Conference news Email bulletin archive